Multidrug-resistant TB

Multidrug-resistant TB (MDR-TB) begins when an antibiotic fails to eradicate all the bacteria that it targets, with the surviving bacteria producing resistance to that antibiotic and usually others at the same time. Primary Multidrug resistant, MDR-TB occurs in patients who was not earlier been infected with TB but who became infected with a strain which is resistant to the treatment. Acquired multidrug resistance for TB occurs in patients during treatment with a drug regimen that is not competent of killing the particular strain of TB with which they have been infected. MDR-TB requires treatment with second-line drugs, often four or more anti-TB drugs for a minimum of 6 months and a maximum for 18–24 months, if rifampin resistance has been identified in the specific strain of TB with which the patient has been infected. Under ideal program conditions, MDR-TB cure rates can approach 70%. In general, second-line drugs are less effective, more toxic and much more expensive than first-line drugs.

  • New drugs and new targets
  • New resistance mechanisms
  • Management of contacts of drug-resistant TB patients
  • MDR-TB treatment strategies in people living with HIV

Related Conference of Multidrug-resistant TB

April 08-09, 2019

2nd Global experts meet on STD-AIDS and Infectious Diseases

Wellington, New Zealand
April 22-23, 2019

World Congress on Advancements in Tuberculosis and Lung Diseases

| Radisson Hotel Narita | Tokyo, Japan
June 17-18, 2019

9th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
July 29-30, 2019

Annual Meeting on Infectious Diseases

Amsterdam, Netherlands
September 09-10, 2019

12th Global Infections Conference

Singapore
September 23-24, 2019

11th Euro-Global Conference on Infectious Diseases

London, UK
September 23-24, 2019

International Conference on Tropical Medicine and Infectious Diseases

| Radisson Hotel Narita | Tokyo, Japan
September 26-27, 2019

10th Annual Congress on Rare Diseases and Orphan Drugs

Charlottesville | Virginia | USA
October 21-22,2019

5th Annual Congress on Infectious Diseases

Frankfurt, Germany
October 21-22, 2019

15th World Congress on Infection Prevention and Control

Zurich, Switzerland
November 15-16, 2019

Infertility, IVF

Tokyo, Japan
November 18-19, 2019

7th Annual Conference on Parasitology & Infectious Diseases

Johannesburg, South Africa
December 02-03, 2019

2nd World Congress on Rare Diseases

Helsinki, Finland
Feb 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany

Multidrug-resistant TB Conference Speakers

Recommended Sessions

Related Journals

Are you interested in